Pfortmueller, Carmen A.
Ott, Isabelle
Müller, Martin
Wilson, Darius
Schefold, Joerg C.
Messmer, Anna S.
Article History
Received: 23 May 2024
Accepted: 2 September 2024
First Online: 8 September 2024
Change Date: 20 November 2024
Change Type: Update
Change Details: The original online version of this Article was revised: The original version of this Article was published incorrectly under licence CC BY-NC-ND. The licence has been corrected to CC BY.
Competing interests
: Full departmental disclosure: ASM, CAP and JCS report grants from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Phagenesis, Cytel, and Nycomed outside the submitted work. The money was paid into departmental funds; no personal financial gain applied. All other authors have nothing to disclose.
: The Ethical Committee on human research of the Canton of Bern (EC no.: 2016-01039) approved the study, and written informed consent was sought from all participants prior to inclusion.